On Tuesday, February 4, hundreds of Georgia pharmacy students have put on their white coats to gather at the Georgia State Capitol for one of GPhA's most anticipated annual advocacy events created solely for Georgia student pharmacists.
Among the future pharmacy leaders, is Innovation Compounding intern and Mercer University Student Pharmacist Class of 2022 candidate, Savannah Cunningham.
Last year, Savannah joined our advocacy staff to meet face-to-face with legislators for the 2019 Compounders on Capitol Hill event in Washington, DC.
As a fierce advocate of pharmacy compounding at both the state and national level, we are proud to see Savannah continue to flex her political muscle and making her voice heard.
For further detail about the event or to learn more about our advocacy work, read the blogs for each event.
UGA & PCOM Day at the Dome 2020
Shawn Hodges, PharmD, Named President of Alliance for Pharmacy Compounding
Compounders on Capitol Hill - CCH 2019
Education & Advocacy - CCH 2018
Innovation on Capitol Hill 2018
Connect with Us
If you have any questions or would like additional information, please contact Innovation Compounding at 1-800-547-1399, Monday-Friday, 9 a.m. to 5 p.m. EST, excluding all major holidays.
Medical Disclaimer This content is for informational and educational purposes only. It is not intended to provide medical advice or take the place of such information or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Innovation Compounding, Inc. nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any medication, nutritional supplement, diet, or health regimen. Innovation Compounding does not make or intend to make any claims to efficacy or safety of compounded products for specific conditions or disease states, as compounded products are not FDA-approved for these conditions.